| I've got Craig Levein's naked bum on my computer, reveals Lorraine
The Tannadice boss left himself exposed at the back when he starred in a lighthearted video to raise awareness of prostate cancer. And breakfast telly queen Lorraine was so impressed by Craig's performance that she has made his rear end her screensaver on her PC. United's most famous supporter said yesterday: "Well done, Craig Levein. You've made us all very happy. "The video is very funny - and he's got a good bum!" Craig agreed to star in the video after prostate cancer killed Dundee United chairman Eddie Thompson last year. He gives a spoof "post-match interview" about being checked for the illness, then walks away with his hospital gown hanging open. Rugby ace Chris Paterson and presenter Grant Stott also appear in the film and Lorraine praised them all for getting involved.
Daughter Raises Prostate Cancer Awareness, Runs 5K in Memory of Father
As part of its efforts to raise greater prostate cancer awareness in Denver, the PCEC will also provide information on prostate cancer. "My family learned an important lesson about the value of annual prostate cancer screenings. In honoring my dad's life and his efforts to raise awareness of the disease, we hope others will be inspired to get checked," added Franklin. The PACE Race Series - sponsored by sanofi-aventis to benefit the PCEC - was launched in 2002 to increase national awareness of prostate cancer. In addition to raising awareness, PACE Race events often include special recognition of survivors and caregivers, Prostate Specific Antigen (PSA) blood screenings, "Ask a Doctor" booths, along with entertainment, fun and giveaways. The Assurant Health RunDenver Series of foot races, sponsored by Milwaukee, WI-based Assurant Health, a national provider of individual medical, small group and specialty health insurance, which included four races culminating in March at That Dam Run, marked the beginning of the 2009 PACE Race Series.
Sreekumar's big day
Sreekumar was the lead author of research that could provide significant advances in the diagnosis and treatment of prostate cancer. The research of Sreekumar and his team looked at more than 1,000 metabolites, or small molecules, in tissues associated with prostate cancer and identified 10 that were present more often in aggressive and advanced prostate cancers. Sreekumar discovered that one metabolite, sacrosine, is a strong indicator of advanced disease. His hope is that a test for sacrosine and other key metabolites can be developed to help doctors distinguish between benign prostate tumors and aggressive ones. "The PSA is the clinical standard prostate cancer test, but it has a very high false positive rate," he said. That forces doctors to do a large number of needle biopsies to determine if the tumor is growing and how fast.
NAACP Image Awards to honor Muhammad Ali
It was during a routine physical last September that a blood test turned up signs of prostate cancer. A biopsy and follow-up examination confirmed the diagnosis. When Wilson heard his doctor utter the word cancer, “I just felt devastated," he said. But Wilson also noticed that his doctor “had this little smile on his face" as he delivered the news. The reason, he said, was because his doctor told him: “We caught it early enough and we can knock it out." Carnie Phillips to host next ‘Newlywed Game' LOS ANGELES — Here comes the next “Newlywed Game" host. Carnie Wilson, the Wilson Phillips singer who hosted her own talk show and appeared on VH1's “Celebrity Fit Club," is slated to host 40 episodes of a new GSN edition of the show where newly married couples answer questions to find out how well they know each other.
Learn to Love: Cauliflower
Cruciferous veggies may help prevent cancer, and they are known to reduce the risk of lung, colon, breast, ovarian, and bladder cancers. This class of veggies, cauliflower included, also benefit the liver and the cardiovascular system. The reasons to love cauliflower are plentiful! Not sure how to cook it? See my new favorite way to prepare cauliflower when you read more. .
Black Journalist Criticized for Attacking Michelle Obama
Carmichael continued to support a revolution as the answer to the problems of racism and unfairness until his death from prostate cancer in Conakry, Guinea, West Africa in 1998. "It is inappropriate to use his memory as a weapon to try to smear the beautiful image of our new First Lady," Black Women for Obama stated. "We resent the sexist and bizarre attempt to compare the nation's elegant and graceful First Lady to a man in a dress." Media Matters which publicized Williams' comments, also lashed out at the Fox political contributor and author of several books, including Eyes on the Prize: America's Civil Rights Years. “Juan Williams again baselessly attacked Michelle Obama and provided no evidence," wrote mediamatters.org, a web-based progressive information media watchdog group dedicated to monitoring conservative “misinformation." Referring to the Aug.
New Alta. MRI machine could dramatically improve tumour treatment.
Such a machine could help doctors better control lung, breast, brain, abdominal and prostate tumours. It would provide precise magnetic resonance images of where the tumours are in the body, even if they move during treatment, said Gino Fallone, a medical physicist at the Cross Cancer Institute in Edmonton, who was part of the team that built the machine. Doctors could then use higher levels of radiation since they wouldn't be as worried about hitting healthy tissue around the tumour. ``Nobody cures cancer,'' Fallone said, but such a machine has the potential to increase tumour control by 20 to 40 per cent, which means it could significantly increase rates of survival and prolong life. Scientific and clinical teams across the world have been trying for years to invent such a machine.
‘Breast cancer awareness must be raised in Turkey’
And while lung, stomach, bladder, colon, laryngeal and prostate cancer are the most common types of cancer in men, breast cancer is the leading type of cancer seen in women. Even though breast cancer can be treated successfully when diagnosed early, thousands of women still die from the disease each year, and experts say breast cancer awareness in Turkey is at an inadequate level. TKASK President Professor Tezer Kutluk, who is also on the board of the International Union Against Cancer (UICC), told Sunday's Zaman that even though breast cancer awareness in Turkey has increased recently, it is still far behind that in developed Western countries. "Methods such as breast self-exams and mammography for early diagnosis are not employed at a sufficient level in our country. We have had an information line open for over a year to inform people about breast cancer, and we have launched campaigns with AVON [a beauty product retailer] to raise awareness," he said.
UK’s first double high-dose cancer treatment delivered in Bristol
Patients are normally suffering from locally-advanced prostate cancer and receive brachytherapy as a boost prior to receiving a full course of external beam radiotherapy. Bristol Oncology Centre, which serves 2.4 million people in the Avon, Somerset and Wiltshire region, has been using a Varian GammaMed afterloader since 2005. The device is used in combination with BrachyVision treatment planning software, which enables clinicians to plan treatments by combining and using MRI, CT and 3D scans for the best possible images of the tumor and surrounding organs. .
ImmunoCellular Therapeutics Identifies Novel Peptides to Broaden
While glioblastoma will be the initial target for ICT-121, CD133 is also overexpressed in colon cancer, breast cancer, liver cancer, prostate cancer, multiple myeloma and melanoma, providing many potential cancer targets for this CSC vaccine in the future. About ImmunoCellular Therapeutics, Ltd. IMUC is a Los Angeles-based clinical-stage company that is developing immune based therapies for the treatment of brain and other cancers. IMUC is currently evaluating a dendritic cell-based vaccine in a Phase I clinical trial for glioblastoma. The company's "off the shelf? therapeutic vaccine product candidate targeting cancer stem cells for multiple cancer indications is expected to enter clinical trials during the third quarter of 2009. IMUC is in pre-clinical development of a monoclonal antibody product candidate for the treatment of small cell lung cancer and pancreatic cancer, and is also evaluating its platform technology for monoclonal antibody discovery using differential immunization for diagnosing and treating multiple types of cancer.
|
